Skip to main content
. 2019 Mar 7;12(1):91–102. doi: 10.1159/000495851

Table 3.

BMI z-score velocity (see Methods) in n = 7 patients with hypothalamic obesity undergoing individual treatment attempts with dextroamphetamine before the initiation and during the course of stimulant treatment

Patient
ID
BMI z-score velocity before insult BMI z-score at hypothalamic insult BMI z-score at start dextroamphetamine BMI z-score velocity before dextroamphetamine BMI z-score velocity 1st year dextroamphetamine BMI z-score velocity 2nd year dextroamphetamine BMI z-score velocity 3rd year dextroamphetamine
1 n.a. –0.30 1.79 0.60 –0.12 0.22 –0.93
2 n.a. 1.86 2.59 n.a. 0.04 0.42 –0.06
3 –0.5 1.35 2.58 0.35 –0.21 –0.34 0.17
4 n.a. 2.62 3.51 n.a. –0.32 –0.21 n.a.
5 n.a. n.a. 4.20 n.a. –0.29 –0.13 –0.11
6 n.a. 1.76 3.09 1.33 –0.11 0.34 n.a.
7 n.a. n.a. 4.38 n.a. –0.22 n.a. n.a.
Total groupa 3.17±0.93 –0.18±0.12 0.05±0.32 –0.23±0.48
Craniopharyngioma groupa 2.62±0.71 –0.15±0.15 0.02±0.36
Othersa 3.89±0.7 –0.21±0.09
a

Mean ± standard deviation.